Journal of AIDS & Clinical Research

Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, NE, USA

Publications

• Mini Review   
  Food and Drug Administration for the treatment of HIV
  Author(s): Nathan Smith*
  
  The HIV/AIDS pandemic continues to pose a significant global health challenge. The development of effective antiretroviral therapies has been crucial in managing the disease. This study examines the recent approval by the Food and Drug Administration of a groundbreaking treatment for HIV and its potential impact on improving patient outcomes. We conducted a comprehensive review of the clinical trials and regulatory processes leading to the FDA approval of the new HIV treatment. Data on safety, efficacy and patient outcomes were analyzed to assess the treatment's effectiveness in comparison to existing therapies. The FDA granted approval for the new HIV treatment based on robust clinical evidence demonstrating its efficacy in suppressing viral replication and improving immunological parameters. The treatment also exhibited a favorable safety profile, with minima.. Read More»
  DOI: 10.37421/2155-6113.2023.14.961

  Abstract HTML PDF